Insider trades

Welgus Howard G., Director of Arcutis Biotherapeutics ARQT, has filed 0 purchases and 34 sales on the open market. Over the past 12 months that comes to a net sale of $1.9M. The latest trade was on 06/17.

Welgus Howard G.

Director
First filing
23/02/21
Trades
74 trades
Buys / sales
0 / 34
12-month net buying
−$1.9M
Last trade
06/17

Trading activity

Transactions

Trade type
ARQT
Open-market sale10b5-1 plan06/15–06/1706/174,731 sh2 trades$24.58avg.$116,283.81−11.1%
Open-market sale10b5-1 plan05/0105/057,144 sh$22.99$164,240.56−18.0%
Open-market sale10b5-1 plan04/0104/0310,000 sh$23.88$238,800−20.1%
Open-market sale10b5-1 plan03/0203/0410,000 sh$25.65$256,500−16.7%
Open-market sale10b5-1 plan02/0202/0410,000 sh$25.05$250,500−14.3%
Open-market sale10b5-1 plan01/0201/0610,000 sh$28.96$289,600−12.5%
Open-market sale10b5-1 plan25/12/0125/12/0310,000 sh$30.21$302,100−11.1%
Open-market sale10b5-1 plan25/11/0325/11/0510,000 sh$25.27$252,700−10.0%
ARQT
Open-market sale10b5-1 plan25/10/0125/10/0310,000 sh2 trades$18.92avg.$189,200−9.1%
Open-market sale10b5-1 plan25/09/0225/09/0410,000 sh$15.64$156,400−9.1%
ARQT
Open-market sale10b5-1 plan25/08/0125/08/0510,000 sh2 trades$14.30avg.$143,000−9.1%
Open-market sale10b5-1 plan25/07/0125/07/029,208 sh$13.84$127,438.72−8.4%
Open-market sale10b5-1 plan25/06/1825/06/2010,139 sh$13.37$135,558.43−8.5%
Open-market sale10b5-1 plan25/05/0125/05/0510,000 sh$14.64$146,400−8.2%
Open-market sale10b5-1 plan25/04/0125/04/0310,000 sh$15.12$151,200−7.6%
Open-market sale10b5-1 plan25/03/0325/03/0410,000 sh$13.00$130,000−7.0%
Open-market sale10b5-1 plan25/02/0325/02/0410,000 sh$12.71$127,100−6.6%
Open-market sale10b5-1 plan25/01/0225/01/0610,000 sh$14.67$146,700−6.2%
Open-market sale10b5-1 plan24/12/0224/12/0310,000 sh$12.51$125,100−5.8%
Open-market sale10b5-1 plan24/11/0124/11/0510,000 sh$8.65$86,500−5.5%